[VRTX] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
01-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -32.33%
YoY- -148.00%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 417,935 144,556 351,157 333,994 563,340 65,524 33,889 51.97%
PBT -77,829 -178,594 -340,253 -80,772 210,801 -170,972 -642,178 -29.64%
Tax -1,379 2,043 -155,704 -2,696 22,660 -29,274 -483,534 -62.32%
NP -75,512 -176,656 44,285 -76,148 158,629 -180,392 -158,644 -11.63%
Tax Rate - - - - -10.75% - - -
Total Cost 493,447 321,212 306,872 410,142 404,711 245,916 192,533 16.97%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -18.07 -122.21 12.61 -22.80 28.16 -275.31 -468.13 -41.85%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -0.31 -0.74 0.19 -0.35 0.76 -0.89 -0.80 -14.60%
EPS Diluted -0.31 -0.74 0.19 -0.35 0.72 -0.89 -0.80 -14.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.